Physician profile
Andrew M Stein
NPI 1801891619
$2,851.61
in general payments reported to CMS, 2019-2025
21 companies · $877 in 2025
The $877 reported for 2025 was more than what a typical Otolaryngic Allergy provider received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $38.77 · 2021: $355 · 2022: $616 · 2023: $248 · 2024: $604 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,728.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $787.88 | 2020-2025 | |
| Glaxosmithkline, LLC. | $431.05 | 2021-2025 | Nucala |
| Lucid Diagnostics INC. | $350.19 | 2022 | |
| Optinose US, INC. | $293.68 | 2021-2025 | |
| Stryker Corporation | $232.92 | 2019-2025 | Scopis Ent |
| Astrazeneca Pharmaceuticals LP | $167.65 | 2021-2025 | Tezspire, Fasenra |
| Regeneron Healthcare Solutions, INC. | $126.74 | 2019-2024 | Dupixent, Libtayo |
| Genentech USA, INC. | $113.76 | 2023-2025 | Xolair |
| Novartis Pharmaceuticals Corporation | $48.86 | 2021-2022 | |
| Kaleo, INC. | $47.90 | 2020-2021 | |
| Acclarent, INC | $42.00 | 2023 | Acclarent Aera |
| Phadia US INC. | $37.97 | 2021-2022 | |
| Aerin Medical INC. | $28.13 | 2025 | |
| Merck Sharp & Dohme LLC | $27.87 | 2021-2023 | |
| Lilly USA, LLC | $25.20 | 2025 | Ebglyss |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.69 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $16.29 | 2021 | |
| Amgen INC. | $15.98 | 2025 | Tezspire |
| Smith+Nephew, INC. | $15.43 | 2019 | |
| Integra Lifesciences Corporation | $12.29 | 2022 | |
| Microline Surgical INC | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.